Breaking News Instant updates and real-time market news.

AVAV

AeroVironment

$22.88

-0.28 (-1.21%)

07:40
10/13/16
10/13
07:40
10/13/16
07:40

AeroVironment assumed with a Hold at Canaccord

Canaccord analyst Ken Herbert assumed coverage on AeroVironment with a Hold rating as he sees near-term risk to the 2017 outlook considering the lower level of current year sales in the backlog. He also cites timing risk from the continuing resolution and passage of the 2017 Defense budget, as well as FMS approvals from the upcoming elections. Herbert lowered the firm's price target to $27 from $28 on AeroVironment shares.

AVAV AeroVironment
$22.88

-0.28 (-1.21%)

10/06/16
BARD
10/06/16
INITIATION
Target $24
BARD
Neutral
AeroVironment initiated with a Neutral at Baird
Baird analyst Peter.Arment initiated AeroVironment with a Neutral and a $24 price target.
08/31/16
RAJA
08/31/16
NO CHANGE
RAJA
Market Perform
Raymond James sees potential turbulence ahead for AeroVironment
Raymond James analyst Brian Gesuale says that despite the company's Q1 gross margin weakness and EPS shortfall, AeroVironment maintained its outlook for the year based on confidence that a pickup in Q2 bookings and better visibility will reinforce its prior guidance. However, the analyst sees potential turbulence ahead and trimmed his full-year estimate as his conviction that AeroVironment can hit its 2017 mark has waned. Gesuale reiterates a Market Perform rating on the shares.
08/31/16
PIPR
08/31/16
NO CHANGE
Target $31
PIPR
Overweight
AeroVironment selloff provides value buying opportunity, says Piper Jaffray
Piper Jaffray analyst Troy Jensen views the post-earnings selloff in shares of AeroVironment as a good value buying opportunity for longer-term investors. While Q1 missed expectations, the company remains confident on financial targets for the full year and reiterated FY17 guidance, Jensen tells investors in a post-earnings research note. He continues to like AeroVironment's positioning in fast emerging high growth markets. The analyst lowered his price target for the shares to $31 from $37 and keeps an Overweight rating on the name.
06/01/16
PIPR
06/01/16
NO CHANGE
Target $36
PIPR
Overweight
AeroVironment should be bought ahead of mid-June ruling, says Piper Jaffray
Piper Jaffray analyst Troy Jensen recommends buying shares of AeroVironment in front of the release of the Federal Aviation Administration's small unmanned aircraft systems ruling expected in mid-late June. The analyst believes the ruling will represent the "first big commercial drone catalyst" for the company. The rules will likely be an incremental catalyst to AeroVironment's Commercial business and spark interest from the investment community, Jensen tells investors in a research note. He reiterates an Overweight rating on the shares with a $36 price target.

TODAY'S FREE FLY STORIES

OMED

OncoMed

$3.77

0.04 (1.07%)

16:48
04/24/17
04/24
16:48
04/24/17
16:48
Hot Stocks
OncoMed announces workforce reduction »

OncoMed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Hot Stocks
Express Scripts down 12% after contract with Anthem unlikely to be renewed »

In after hours trading,…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Earnings
Owens-Illinois sees FY17 EPS $2.40-$2.50, consensus $2.43 »

The Company continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:45
04/24/17
04/24
16:45
04/24/17
16:45
Hot Stocks
Breaking Hot Stocks news story on Express Scripts »

Express Scripts trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Earnings
Owens-Illinois reports Q1 EPS 58c, consensus 53c »

Reports Q1 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Hot Stocks
Federal Reserve, FDIC approve revised Wells Fargo living will »

The Federal Deposit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:43
04/24/17
04/24
16:43
04/24/17
16:43
Hot Stocks
Express Scripts CEO: 'Perplexed' by potential loss of Anthem contract »

Says Anthem deal is…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

SMMF

Summit Financial Group

$23.00

0.28 (1.23%)

16:41
04/24/17
04/24
16:41
04/24/17
16:41
Hot Stocks
Summit Financial Group announces resolution of litigation »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$80.05

0.77 (0.97%)

, ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Breaking Hot Stocks news story on CVS Health, Express Scripts, Anthem »

CVS up 2% after Express…

CVS

CVS Health

$80.05

0.77 (0.97%)

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 02

    May

  • 10

    May

  • 18

    May

  • 06

    Jun

NVS

Novartis

$74.61

1.21 (1.65%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Novartis expands pact with Amgen to commercialize AMG 334 for migraine »

Novartis (NVS) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 06

    Jun

  • 26

    Jun

HMN

Horace Mann

$39.25

0.15 (0.38%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Earnings
Horace Mann reports Q1 EPS 37c with items, may not compare to consensus 55c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WNC

Wabash

$20.36

0.64 (3.25%)

16:36
04/24/17
04/24
16:36
04/24/17
16:36
Earnings
Breaking Earnings news story on Wabash »

Wabash sees FY17 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 23

    May

  • 24

    May

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:36
04/24/17
04/24
16:36
04/24/17
16:36
Periodicals
Breaking Periodicals news story on Wells Fargo »

Fed clears Wells Fargo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

WNC

Wabash

$20.36

0.64 (3.25%)

16:35
04/24/17
04/24
16:35
04/24/17
16:35
Earnings
Wabash reports Q1 EPS 32c, consensus 27c »

Reports Q1 revenue $363M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 23

    May

  • 24

    May

BCR

C.R. Bard

$302.41

49.34 (19.50%)

, BDX

Becton Dickinson

$177.07

-8.22 (-4.44%)

16:34
04/24/17
04/24
16:34
04/24/17
16:34
General news
On The Fly: Top stock stories for Monday »

Stocks began the session…

BCR

C.R. Bard

$302.41

49.34 (19.50%)

BDX

Becton Dickinson

$177.07

-8.22 (-4.44%)

PPG

PPG

$108.01

2.07 (1.95%)

AKZOY

AkzoNobel

$29.73

1.77 (6.33%)

ARNC

Arconic

$26.10

0.1 (0.38%)

HAS

Hasbro

$101.70

5.67 (5.90%)

SRPT

Sarepta

$34.02

1.41 (4.32%)

W

Wayfair

$43.48

-2.48 (-5.40%)

AMZN

Amazon.com

$907.41

8.88 (0.99%)

HLX

Helix Energy

$6.06

-1.03 (-14.53%)

HAL

Halliburton

$46.75

-0.31 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 01

    May

  • 01

    May

  • 03

    May

  • 04

    May

  • 09

    May

  • 16

    May

  • 17

    May

  • 17

    May

  • 18

    May

  • 23

    May

  • 31

    May

  • 06

    Jun

PII

Polaris Industries

$83.14

1.28 (1.56%)

16:34
04/24/17
04/24
16:34
04/24/17
16:34
Hot Stocks
Polaris Industries discontinuing manufacturing at its plant in Milford, Iowa »

Polaris Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

UIS

Unisys

$11.15

0.2 (1.83%)

16:33
04/24/17
04/24
16:33
04/24/17
16:33
Earnings
Unisys sees FY17 revenue $2.65B-2.75B, consensus $2.71B »

Sees FY17 non-GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

CVRS

Corindus

16:33
04/24/17
04/24
16:33
04/24/17
16:33
Hot Stocks
Corindus announces strategic partnership with BLOXR »

Corindus Vascular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

HSTM

HealthStream

$23.62

-0.08 (-0.34%)

16:32
04/24/17
04/24
16:32
04/24/17
16:32
Earnings
HealthStream backs FY17 consolidated revenue growth view of 10%-14% »

Consensus $252.3M. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

UIS

Unisys

$11.15

0.2 (1.83%)

16:32
04/24/17
04/24
16:32
04/24/17
16:32
Earnings
Unisys reports Q1 EPS (65c), consensus (60c) »

Reports Q1 revenue $665M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

AMGN

Amgen

$163.14

2.73 (1.70%)

, NVS

Novartis

$74.61

1.21 (1.65%)

16:32
04/24/17
04/24
16:32
04/24/17
16:32
Hot Stocks
Amgen announces expanded collarboration with Novartis for erenumab »

Amgen (AMGN) announced an…

AMGN

Amgen

$163.14

2.73 (1.70%)

NVS

Novartis

$74.61

1.21 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 06

    Jun

  • 26

    Jun

  • 19

    Jul

  • 14

    Aug

HSTM

HealthStream

$23.62

-0.08 (-0.34%)

16:31
04/24/17
04/24
16:31
04/24/17
16:31
Earnings
HealthStream reports Q1 EPS 4c, consensus 4c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

RE

Everest Re

$239.38

5.65 (2.42%)

16:31
04/24/17
04/24
16:31
04/24/17
16:31
Earnings
Everest Re reports Q1 after-tax operating EPS $6.29, consensus $5.31 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

16:31
04/24/17
04/24
16:31
04/24/17
16:31
Options
Preliminary option volume of 18.1M today »

Preliminary option volume…

CTRV

ContraVir Pharmaceuticals

$1.18

-0.23 (-16.31%)

16:30
04/24/17
04/24
16:30
04/24/17
16:30
Syndicate
ContraVir Pharmaceuticals files to sell common stock and warrants »

ContraVir intends to use…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.